Predictive Vulnerability Intelligence.

Product

  • Product
  • Pricing
  • Documentation

Company

  • About
  • Partnerships
  • Blog
  • Support

Legal

  • Terms
  • Privacy
  • Data Licensing

© 2026 FAUCET Technologies LLC. All rights reserved.

CVE-2019-15931

29
FAUCET Score

CVE-2019-15931 describes a critical directory traversal vulnerability affecting Intesync Solismed 3.3sp, distinct from CVE-2019-16246. With a CVSS score of 9.8, this flaw allows unauthenticated attackers to achieve full compromise of confidentiality, integrity, and availability over a network with low attack complexity. Despite its critical severity, there is no evidence of active exploitation, publicly available exploit code (Metasploit, Nuclei, ExploitDB), or significant community discussion or media coverage.

Impacted Technologies

VendorProductVersion(s)CPE
3.3CPE matchmatch criteria
cpe:2.3:a:intesync:solismed:3.3:sp1:*:*:*:*:*:*

CVSS Data

CVSS version used by this source: 3.1

9.8CRITICAL

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

Attack Vector
NETWORK
Attack Complexity
LOW
Privileges Required
NONE
User Interaction
NONE
Scope
UNCHANGED
Confidentiality Impact
HIGH
Integrity Impact
HIGH
Availability Impact
HIGH
Exploitability Score
3.9
Impact Score
5.9
CvssVersion
3.1

Exploit Intelligence

EPSS Score
2.73%
Probability of exploitation in next 30 days
EPSS Percentile
84.5%
Percentile rank of EPSS score among Peer Group
As of 2026-07-24
Model: v2026.06.15
This CVE's current EPSS score of 0.0272 is in the 75th percentile among its peer group of 36,821 CVEs.

Social Chatter

The average CVE in this peer group has 0.0 Twitter, 0.1 Reddit, 0.3 Bluesky, 0.3 Mastodon, and 2.4 GitHub mentions.

Media Mentions

No media coverage found for this CVE.

The average CVE in this peer group has 0.3 InfoSec Media, 0.0 Vendor Blog, and 0.0 Security Researcher mentions.

Remediation

Remediation records are not available for this CVE.

References

bishopfox.com
Third Party Advisory
know.bishopfox.com / advisories/solismed-critical
ExploitThird Party Advisory
bishopfox.com / blog/news-category/advisories
Third Party Advisory
solismed.com
Product